Asprosin was recently identified by Romere et al (3) through an investigation of Neonatal Progeroid Syndrome (NPS); a disorder characterised by reduced insulin despite maintenance of euglycemia, extreme leanness and partial lipodystrophy (4). The gene discussed is FBN1; the disease is nail-patella syndrome.